Blog

The Part of Sales You Can’t Automate You hear a lot about sales and marketing. Funnels, CRMs, ideal customer profiles, lead generation, conversion rates, messaging, campaigns. There are a lot of tools, strategies and systems out there designed to help us do it better. But after a recent Sales workshop at Edmonton Unlimited, the conversation […]

Before BioWare Was BioWare It started with three doctors, some medical education software and an idea kicked around over lunch. Why not start a company and make video games? As co-founder Dr. Ray Muzyka joked at a recent Threshold Impact Venture Mentoring Service (VMS) event hosted at Edmonton Unlimited: how hard could it be? Pretty

For many founders, growth comes down to one question: How do we move faster without stretching our resources too thin? Hiring specialized talent, advancing research, and developing new products all require investment. For many early-stage companies, those investments compete with everything else needed to build a business. During a recent presentation at Edmonton Unlimited, Sherifat

For many life sciences founders, intellectual property starts with a patent. But as Dentons lawyers Jaclin Cassios, Counsel, and Heather Barnhouse KC, ICD.D, FEA, Partner, explained during a recent Edmonton Unlimited workshop, that’s only part of the story. For life sciences companies, intellectual property isn’t simply a legal consideration. It’s often the foundation of the

Municipal leaders from across Canada gathered at MacEwan University during the Federation of Canadian Municipalities Conference to explore Edmonton’s experience as Canada’s first UNESCO Learning City. The discussion brought together perspectives from the City of Edmonton, MacEwan University, Edmonton Public Library, Qualico Canada, and Edmonton Unlimited to examine how learning contributes to economic development, talent

Startup Genome and Edmonton Unlimited unveil the world’s most comprehensive report on startup ecosystems, the 2026 Global Startup Ecosystem Report, at VivaTech Paris. SAN FRANCISCO, Calif. — June 17, 2026 — The 2026 Global Startup Ecosystem Report (GSER) by Startup Genome and the Global Entrepreneurship Network launched today at Vivatech Paris. Powered by the world’s

One of the most valuable aspects of the Federation of Canadian Municipalities (FCM) Conference is the opportunity for municipal leaders to step outside the conference venue and experience firsthand what’s happening in communities across the country. As part of this year’s conference, a group of delegates visited Edmonton Unlimited for a Study Tour focused on

For many founders, fundraising starts with a pitch deck. Patrick Lor, Managing Partner, Panache Ventures suggested it should start somewhere else: trust. Drawing on years of experience building companies, reviewing thousands of pitches, and investing in early-stage startups, the session explored a more fundamental question: what causes investors to believe in a founder? Rather than

While the Deep Tech Showcase investor panel explored what makes a company investable, the event’s fireside chat offered a different perspective: what it looks like to build a deep tech company while actively navigating the realities of growth. Moderated by Arden Tse, Principal at Yaletown Partners, the conversation featured Chris Robson and Callie Lissinna, Co-Founders

Edmonton’s deep tech ecosystem is gaining momentum, driven by world-class research, emerging founders, and technologies with the potential to solve some of the world’s biggest challenges. To explore what it takes to turn breakthrough innovation into investable companies, Edmonton Unlimited welcomed founders, investors, researchers, and ecosystem leaders to its Deep Tech Showcase on June 9.

Each year, CANSEC brings together defence leaders, government officials, major contractors, and innovators from across Canada to discuss the future of defence and security. For our Defence Industry Liaison, Trevor Friesen, attending was less about following industry headlines and more about understanding where new opportunities may be emerging for Edmonton companies and the founders building

Drug discovery runs on information, but that alone is not enough. Pharmaceutical companies are under pressure to move faster while sorting through enormous amounts of scientific research, clinical trial data, and emerging AI tools. Missing one key detail can send years of research and millions of dollars in the wrong direction. That challenge shaped one